AMBER BESSELMAN: Open Payments
NPI 1063268852 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,149 in 220 payments from 36 companies in 2025. Trend: 2023 $0 · 2024 $2,569 · 2025 $4,149
Food & beverage: $4,149
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $689 |
| PFIZER INC. | 37 | $369 |
| JAZZ PHARMACEUTICALS INC. | 13 | $300 |
| Axsome Therapeutics, Inc. | 9 | $276 |
| Novartis Pharmaceuticals Corporation | 16 | $233 |
| UCB, Inc. | 11 | $198 |
| Lundbeck LLC | 7 | $167 |
| ARGENX US, INC. | 6 | $162 |
| Lilly USA, LLC | 8 | $152 |
| Neurocrine BioSciences, Inc. | 4 | $101 |
Products named: QULIPTA, NURTEC ODT, KESIMPTA, BOTOX, VYVGART HYTRULO, Symbravo, XYWAV, VYEPTI.
Industry payments across FL — which companies pay providers there.
